Argatroban
| CAS No. | 74863-84-6 | Cat. No. | BCP06831 |
| Name | Argatroban | ||
| Synonyms | MCI-9038; MCI9038; MCI9038; MD805; MD-805; MD 805; DK-7419; DK 7419; DK7419; GN1600; GN-1600; GN 1600; MMTQAP; MPQA;Argipidine;Acova; | ||
| Formula | C23H36N6O5S | M. Wt | 508.63 |
| Description | Argatroban may have a complementary effect for preventing thrombus formation without aggravating bleeding tendency because of its monotarget specificity to thrombin. Administration (0.5 to 2 micrograms/kg/min) of argatroban is a safe anticoagulant for left heart bypass in repairs of traumatic aortic rupture associated with multiple organ injuries. Argatroban, as compared with heparin, appears to enhance reperfusion with TPA in patients with AMI, particularly in those patients with delayed presentation. The incidences of major bleeding and adverse clinical outcome were lower in the patients receiving argatroban. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | Thrombin | ||
|
Superhydrophobic hemostatic nanofiber composites for fast clotting and minimal adhesion
Publications Citing of Biochempartner's Argatroban(CAS:74863-84-6) |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.